Cargando…
Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz
Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI), used for the treatment of human immunodeficiency virus (HIV)-1 infection. Approved by the US Food and Drug Administration in 1998, its indication was recently extended to include children as young as 3 months of age. The World He...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412603/ https://www.ncbi.nlm.nih.gov/pubmed/25937791 http://dx.doi.org/10.2147/PHMT.S47794 |